Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:05 pm Purchase | 2022-04-06 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II, L.P. | 689,910 10.000% | 155,000 (+28.98%) | Filing |
| 2022-02-14 4:20 pm Purchase | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II, L.P. | 534,910 8.000% | 60,235 (+12.69%) | Filing |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II, L.P. | 474,675 9.990% | 474,675 (New Position) | Filing |